Phage offer a real alternative [1] (multiple letters)

Nature Biotechnology

Volumn 22, Issue 5, 2004, Pages 505-507

  Schoolnik, Gary K ^a   Summers, William C ^b   Watson, James D ^c   Projan, Steven ^d  

^a STANFORD UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Simons Center for Quantitative Biology   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACTERIOPHAGE DNA; CHLORAMPHENICOL; COTRIMOXAZOLE; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIOPHAGE; BORDETELLA; COLIPHAGE; COLIPHAGE K1-5; DRUG MANUFACTURE; DRUG RESEARCH; DRUG SAFETY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HERXHEIMER REACTION; HUMAN; IN VITRO STUDY; LETTER; NONHUMAN; PRIORITY JOURNAL; SPECIES IDENTIFICATION; STRAIN IDENTIFICATION;

BACTERIA; BACTERIOPHAGES; BIOLOGICAL THERAPY;

BACTERIA (MICROORGANISMS); BORDETELLA; ESCHERICHIA COLI; NEGIBACTERIA;

EID: 2342454429     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0504-505     Document Type: Letter

References (0)